NetraMark Holdings, Inc. engages in the development of artificial intelligence and machine learning solutions. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-06-08. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.
AINMF stock price ended at $0.81 on 星期四, after dropping 2.41%
On the latest trading day Jan 22, 2026, the stock price of AINMF fell by 2.41%, dropping from $0.83 to $0.81. During the session, the stock saw a volatility of 2.47%, with prices oscillating between a daily low of $0.81 and a high of $0.83. On the latest trading day, the trading volume for AINMF rose by 950 shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 1.4K shares were traded, with a market value of approximately $69.5M.